Iterum Therapeutics plc Ordinary Share (ITRM) is a publicly traded Healthcare sector company. As of May 21, 2026, ITRM trades at $0.03 with a market cap of $1.60M and a P/E ratio of -0.04. ITRM moved -28.57% today. Year to date, ITRM is -94.99%; over the trailing twelve months it is -97.56%. Its 52-week range spans $0.03 to $3.02. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces ITRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Iterum Therapeutics plc Ordinary Share (ITRM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ITRM moved -28.57% today. Analyst consensus is hold.
| Metric | Value |
|---|---|
| Price | $0.03 |
| Market Cap | $1.60M |
| P/E Ratio | -0.04 |
| EPS | $-0.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.02 |
| 52-Week Low | $0.03 |
| Volume | 65.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $390.00K |
| Net Income | $-26.96M |
| Gross Margin | 0.00% |
1 analysts cover ITRM: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.